Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee

Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee

Cancer is rapidly on the rise as a cause of morbidity and mortality in low- and middle-income countries (LMICs). However, despite the increasing importance of immune checkpoint inhibitors (ICIs) as a pillar of cancer therapy, access in these settings lags well behind that in high-income countries (H...

Full description

Saved in:
Bibliographic Details
Main Authors: T Peter Kingham, Innocent Adoubi, Avery D Posey, Ahmad A Tarhini, David R Kaufman, Jyoti Bajpai, Solmaz Sahebjam, Mauricio Burotto, Verna Vanderpuye, Thomas S Uldrick, Olufunmilayo I Olopade, Thomas A Odeny, Wilfred Ngwa, Jennifer Dent, Micaella Jorge, Nora Sobrevilla, Huwaida Bulhan, Gideon T Dosunmu, Lilian Ekpo, Satish Gopal, Manuel R Espinoza-Gutarra, N’da Marcelin Homian, Clarissa Mathias, Nixon Niyonzima, Blaise Nkegoum, Regina Switzer
Format: Article
Language:English
Published: BMJ Publishing Group 2025-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/6/e011258.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jitc.bmj.com/content/13/6/e011258.full

Similar Items